Search results
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 5 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax's updated COVID vaccine is here. What to know about the shot.
Yahoo Life Style via AOL· 7 months agoUnlike Moderna and Pfizer's mRNA vaccines, the Novavax vaccine utilizes a protein-based approach....
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax agrees to pay Gavi in settlement over COVID vaccine contract
BioPharma Dive via Yahoo Finance· 2 months agoDive Brief: Novavax will pay as much as $475 million to settle a dispute with Gavi, the Vaccine...
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Motley Fool via Yahoo Finance· 2 months agoSince 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%....
Novavax COVID vaccine, new 4th option, approved by FDA
NY Daily News via AOL· 2 years agoAmericans will soon have a fourth COVID vaccine option. Novavax’s more traditional vaccine was...
Novavax seeks FDA approval for COVID booster
ABC News via Yahoo News· 2 years agoNovavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults...
This Could Spell Bad News for Novavax
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) investors are likely feeling frustrated. First, they had to wait as the company delayed filing for an Emergency Use Authorization...
Why Novavax Stock Tumbled 28% in the First Half of 2023
Motley Fool· 9 months agoWhat happened Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of...
